Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 23 most recent Form 4 transactions.
| Aug 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER | 403 | — | — | +1.8% | Open the original filing on SEC.gov |
| Jun 30 | KOD | Kodiak Sciences Inc. | AGRANT◆ | 17,731 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | MDGL | Madrigal Pharmaceuticals,… | AGRANT◆ | 766 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | MDGL | Madrigal Pharmaceuticals,… | AGRANT | 454 | — | — | +2.1% | Open the original filing on SEC.gov |
| Jun 15 | TARA | Protara Therapeutics, Inc. | AGRANT◆ | 31,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | MEXER◆ | 2,799 | — | — | — | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 2,026 | — | — | — | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 12,158 | — | — | — | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | MEXER | 2,799 | — | — | +14.6% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 80 | $519.98 | $41.6K | -0.4% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 782 | $518.76 | $405.7K | -3.4% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 1,497 | $517.59 | $774.8K | -6.1% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 723 | $516.87 | $373.7K | -2.9% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 657 | $515.92 | $339K | -2.5% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 343 | $514.67 | $176.5K | -1.3% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 40 | $512.97 | $20.5K | -0.1% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 439 | $512.50 | $225K | -1.7% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 610 | $511.40 | $312K | -2.2% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 151 | $510.36 | $77.1K | -0.5% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 320 | $508.24 | $162.6K | -1.2% | Open the original filing on SEC.gov |
| May 22 | MDGL | Madrigal Pharmaceuticals,… | SSELL◷ | 40 | $506.68 | $20.3K | -0.1% | Open the original filing on SEC.gov |